Search this site powered by FreeFind




Naural Self-Defense Against Breast Cancer - Learning to Cope Successfully with Organochlorine Pollut


What are organochlorines?

Organochlorines are chemicals found in some herbicides and pesticides, in chlorine bleach and most chemical disinfectants, and many plastics, especially PVC (polyvinylchloride).

Organochlorines are implicated in causing and promoting breast cancer because they mutate genes and they cause breast cells to become more receptive to a cancer-promoting chemical called estradiol. Organochlorines weaken the immune system and lower your body's resistance to bacteria and viruses. They also act as a negative type of estrogen in the body.

How do they enter our bodies?

Organochlorines enter our bodies through our drinking water, by eating foods grown with certain agricultural chemicals, and through the plastic linings on canned or microwaveable foods. They enter through our lungs by breathing in the fumes of chlorine bleach disinfectants and by body contact with chlorine bleached paper products such as tampons, toilet paper and paper cups.

How can we reduce our exposure?

Step One-Reduce Your Exposure

The first thing to do is to reduce your plastic consumption, especially of convenience foods. On plastic containers, there is typically a triangle with a number inside of it on the bottom of the container. You can recognize PVC or polyvinylchloride as the type of plastic that has a 3 in the center of the triangle.

As for paper products, use oxygen bleached or unbleached paper products. Companies who sell non-chlorine bleached paper products typically say so on the label and they do not necessarily market their products as "green" products.

Buy the non-chlorine bleach and more environmentally friendly household products. Simple vinegar and water can be used for many household chores. Eating only organically produced meat and dairy products will reduce the amount of organochlorines in your diet by 80%.

Step Two-Help Your Liver

With help, your liver can metabolize organochlorines. Flaxseeds and organic egg yolks contain lecithin, a chemical that speeds up the elimination of fat-soluble chemicals such as organochlorines by making them water-soluble.

Beans, lentils, red clover, soy products and chickweed contain chemicals called saponins. Saponins help to break down organochlorines, prevent cellular mutation and can stop the reproduction of cancer cells. These foods are strongly recommended for anybody who regularly consumes organochlorines.

Members of the cabbage family including broccoli, kale, turnips, radishes, cabbage, bok choy or cauliflower can help you metabolize organochlorines by increasing the production of non-cancerous by-products.

Step Three-Mother Nature's Help

Woman-positive natural sources of estrogen can block entrance of organochlorines, estradiol and other cancer promoting estrogens when enough of them are in the blood stream. The reason behind this is that these positive hormones move quickly through our bodies whereas the cancer producing chemicals such as organochlorines move more slowly. If there are enough of these plant hormones in the blood stream, they can easily block organochlorines from attaching themselves to breast cells and from promoting cancer.

These plant hormones can be found in lentils, dried beans, tofu and fermented soy products such as tempeh and miso, parsnips, sweet potatoes, pomegranates, burdock roots, red clover, hops and ginseng. Regular intake of broccoli and cabbage is also helpful.

Post Transformation Tips

Making changes in favor of your survival and that of the environment often puts us in a period of re-adjustment, not only with the society we live in, but also with our family, friends and neighbors.

Several strategies we use to maintain positive social relations are Natural self-defense does not mean natural aggression, nor does it mean that it will cause you to develop a social disorder triggered by the existence of organochlorines. Foods and herbs that encourage natural self-defense make you lose the taste for products associated with organochlorines.

Allow self-defense foods to empower you to envision and work towards an organochlorine free future without any anger about the present situation. In other words, don't let the forces that encourage personal and environmental negligence push your buttons.

Chose recycled plastic toys or second hand plastic toys over new ones for your children.

Send lunches in reusable containers.

Bring a bean or lentil salad to the next barbecue or potluck supper. Invite friends who use a lot of plastic and organochlorine products over to eat. Explain why you eat certain foods and what you have done to minimize your contribution to its proliferation. Relay the information in such a way that your guests feel comfortable and leave them to lose the taste for organochlorine products in their own way and time.

Use organic foods to show your body what a natural food is and have confidence that your body will use this knowledge to recognize what isn't natural and respond appropriately to it. This is a goal that can be started even on a limited budget. The return of your natural body begins with one organic apple, especially a shared one!

Legal Disclaimer-The information contained in this article is for educational purposes only and is not intended to medically diagnose, treat or cure any disease. Consult a health care practitioner before beginning any health care program.

All contents are copyrighted in 2004 by Agoo Agii,inc. All rights reserved.

Written by Jennifer Rodriguez-Allen, B.Sc., Environmental Chemist and President of Agoo Agii, inc (http://www.agooagii.com/). This article can found in print form with Agoo Agii's Aromatherapy Breast Self-Exam Kit. Gently encourage a loved one (or yourself) perform the Breast Self-Exam.


MORE RESOURCES:
Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal Cancer, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 8/24).

A new promising enzyme target for a specific type of breast cancer, Brk, has been identified in research published on August 21, 2008 in the Proceedings of the National Academy of Sciences (PNAS.) In a specific subset of breast cancer patients, the tumor cells produce high levels of the protein ErbB2 (also called HER2) which pushes the cells to proliferate without limit, a characteristic common of all cancers.

The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders. Established by students, for students, AMSA Academy takes medical students through the core competencies of leadership and project implementation, while building on key principles of important topics in medicine. There are currently 22 programs offered.

Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel. An article on the study titled "Breast Cancer, Psychological Distress and Life Events among Young Women," was just published in the British journal BMC Cancer (8:245, August 2008).

Feelings of happiness and optimism play a positive role against breast cancer. Research published in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease.

New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. The findings suggest a cellular mechanism for the correlation between human breast tissue density and tumor aggressiveness.

Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered.

A new study published on bmj.com argues that for older women, health related quality of life can be improved by hormone replacement therapy (HRT). The authors recommend that HRT guidelines should be revised with this most current evidence taken into consideration. Earlier studies have shown that HRT has the potential for general improvements in quality of life measures - how patients feel or function.

Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected. The researchers also deduced that this molecule -- called largazole -- acts on cells through the same chemical mechanism as other anti-cancer compounds on the market or in clinical trials.

Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. The researchers are combining organic chemistry, computer-aided design and molecular biology techniques in developing and testing pharmaceutical compounds that can fight breast and prostate cancer cells.

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in a global Phase 3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer.

Advocates, including those for breast cancer patients, are concerned about their relationship with pharmaceutical company Genentech following Roche's bid for the company, the

A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D.

Women who survive breast cancer for at least five years after treatment have an 89% chance that they will not have a recurrence of the cancer after 10 years and an 81% chance after 15 years, according to a study published online Tuesday in the Journal of the National Cancer Institute,

Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours. Dr Alexis Willett, Policy Manager at Breakthrough Breast Cancer, says: "Breakthrough welcomes any research which investigates new uses for existing treatments to help benefit people with breast cancer.

An article published in The Lancet Oncology reports that postmenopausal women with breast cancer who are on endocrine treatment are likely to experience arthralgia and arthritis (joint symptoms) if they previously have used hormone replacement therapy (HRT), received a hormone-receptor positive tumor diagnosis, undergone chemotherapy, received treatment with anastrozole versus tamoxifen, or been obese.

Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients.

Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.

Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.

Famous names from the fashion, television, radio and music industries have come together to back Fashion Targets Breast Cancer® (FTBC) UK in an advertising campaign which subtly plays on the topic of celebrity charity endorsement. Natalie Imbruglia, Anna Friel, Alan Carr, Edith Bowman and Twiggy have been shot by acclaimed photographer Rankin wearing their FTBC T-shirts with pride for the campaign from leading charity Breakthrough Breast Cancer which aims to raise £1m.

US researchers estimated that the risk of relapse for breast cancer patients who were cancer-free for five years after systemic therapy (chemotherapy, hormone therapy, or both, as well as surgery) was not negligible although it was probably lower than many people realized.

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer.

American Airlines, the world's largest airline, and Susan G. Komen for the Cure®, the world's largest breast cancer organization, announced an expanded partnership with the unveiling of two specially co-branded aircraft, an American Airlines Boeing 757 and an American Eagle Embraer 145, each incorporating the renowned vivid pink-ribbon motif.

Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase I/II, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with a paclitaxel/bevacizumab regimen in this patient population.

A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome (CS) and related disorders.

home | site map| privacy policy
© 2008, Celerity Consultants, Mumbai, India, All Rights Reserved